Fermenta Biotech Limited (BOM:506414)

India · Delayed Price · Currency is INR

320.60

-8.10 (-2.46%)

At close: Jun 16, 2026

-5.18% (1Y)

Market Cap	9.44B +6.9%
Revenue (ttm)	5.25B +16.7%
Net Income	717.65M -6.6%
EPS	24.51 -7.0%
Shares Out	29.43M
PE Ratio	13.08
Forward PE	n/a
Dividend	3.75 (1.14%)
Ex-Dividend Date	Aug 5, 2026

Volume	23,675
Open	331.45
Previous Close	328.70
Day's Range	315.65 - 342.00
52-Week Range	256.40 - 399.00
Beta	-0.21
Analysts	Strong Buy
Price Target	320.00 (-0.19%)
Earnings Date	May 26, 2026

About Fermenta Biotech

Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally. It provides pharmaceutical formulations and environmental solutions; rents and sells properties; and sports and health awareness/education services. The company also offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for use in various applications, such as pharmaceuticals, dietary and nutritional sup... [Read more]

Industry Pharmaceutical Preparations

Founded 1951

Employees 606

Stock Exchange Bombay Stock Exchange

Ticker Symbol 506414

Full Company Profile

Financial Performance

In fiscal year 2026, Fermenta Biotech's revenue was 5.25 billion, an increase of 11.92% compared to the previous year's 4.69 billion. Earnings were 717.65 million, a decrease of -6.63%.

Financial Statements